Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyskeratosis congenita.

Tom Vulliamy1, Inderjeet Dokal

  • 1Department of Haematology, Division of Investigative Science, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK. t.vulliamy@imperial.ac.uk

Seminars in Hematology
|July 11, 2006
PubMed
Summary

Dyskeratosis congenita (DC) is a rare genetic disorder affecting multiple systems, often presenting with hematologic issues like aplastic anemia. Research suggests DC stems from defective telomere maintenance, impacting stem cell renewal.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TeloNet is born: why all specialities need to be aware of telomere biology disorders.

Frontiers in medicine·2026
Same author

ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.

The Journal of clinical investigation·2025
Same author

Disease characteristics and outcomes of acute myeloid leukemia in germline <i>RUNX1</i> deficiency (Familial Platelet Disorder with associated Myeloid Malignancy).

HemaSphere·2025
Same author

The evolving genetic landscape of telomere biology disorder dyskeratosis congenita.

EMBO molecular medicine·2024
Same author

Nucleotide sugars correlate with leukocyte telomere length as part of a dyskeratosis congenita metabolomic plasma signature.

Haematologica·2024
Same author

New WHO classification of genetic variants causing G6PD deficiency.

Bulletin of the World Health Organization·2024

Area of Science:

  • Genetics
  • Hematology
  • Cell Biology

Background:

  • Dyskeratosis congenita (DC) is a rare inherited disorder.
  • Classically known for mucocutaneous symptoms, DC frequently manifests hematologic abnormalities.
  • The disease can present as aplastic anemia, particularly in its occult form.

Purpose of the Study:

  • To investigate the underlying mechanisms of Dyskeratosis congenita.
  • To explore the link between genetic mutations and cellular pathology in DC.
  • To understand the role of telomere maintenance in the multi-systemic manifestations of DC.

Main Methods:

  • Analysis of genes responsible for X-linked and autosomal dominant forms of DC.
  • Investigation of protein function in ribosome biogenesis and telomerase complex stabilization.
  • Examination of telomere length and its correlation with disease presentation.

Main Results:

  • Mutations in genes related to ribosome biogenesis and telomerase complex stabilization are implicated in DC.
  • Autosomal dominant DC is linked to mutations in the core RNA component of telomerase.
  • Evidence suggests DC is fundamentally a disease of impaired telomere maintenance.

Conclusions:

  • Defective telomere maintenance is the primary pathology in Dyskeratosis congenita.
  • Premature telomere shortening limits stem cell proliferative potential.
  • This explains the observed pathology in tissues requiring constant renewal, such as the hematopoietic system.

Related Experiment Videos